SCHEMBL23498902

SCHEMBL23498902

CCOC(=O)c1c(C)c[nH]c1CC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
CYP3A4 P08684 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
NR1H2 P55055 1/20 0.46
NR1H3 Q13133 1/20 0.46
PDE4D Q08499 1/20 0.44
HPGD P15428 4/20 0.43
MAPT P10636 2/20 0.43
GAA P10253 2/20 0.43
KDM4E B2RXH2 2/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL155605 0.86 SMN1; SMN2 (0.43) ALDH1A1CA12CA1CA2CA7
SCHEMBL27259271 0.85 APLNR (0.44) ALDH1A1CA12CA1CA2CA7
SCHEMBL15061872 0.85 ALDH1A1 (0.42) ALDH1A1CA12CA1CA2CA7
SCHEMBL27259664 0.85 ALDH1A1 (0.47) ALDH1A1CA12CA1CA2CA7
SCHEMBL1316433 0.83 NOTUM (0.57) ALDH1A1CA12CA1CA2CA7
SCHEMBL23498987 0.82 ALDH1A1 (0.40) ALDH1A1CA12CA1CA2CA7
Methane SCHEMBL27742710 0.81 SMN1; SMN2 (0.55) ALDH1A1CA12CA1CA2CA7
SCHEMBL19438592 0.80 ALDH1A1 (0.50) ALDH1A1CA12CA1CA2CA7
SCHEMBL9630478 0.80 KMT2A (0.48) ALDH1A1CA12CA1CA2CA7
SCHEMBL154868 0.79 ALDH1A1 (0.38) ALDH1A1CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024119026-A1 BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME NITTO DENKO CORPORATION (JP) 2024-06-06 WO disclosed
WO-2024119026-A1 BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME NITTO DENKO CORPORATION (JP) 2024-06-06 WO disclosed
WO-2024081802-A1 WAVELENGTH CONVERSION FILM AND DISPLAY DEVICE INCLUDING THE SAME NITTO DENKO CORPORATION (US) 2024-04-18 WO disclosed
US-20230107941-A1 HEPATITIS B CAPSID ASSEMBLY MODULATORS VenatoRx Pharmaceuticals, Inc. 2023-04-06 US disclosed
WO-2021119081-A1 HEPATITIS B CAPSID ASSEMBLY MODULATORS VenatoRx Pharmaceuticals, Inc. (US) 2021-06-17 WO disclosed
WO-2021119081-A1 HEPATITIS B CAPSID ASSEMBLY MODULATORS VenatoRx Pharmaceuticals, Inc. (US) 2021-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230107941-A1 HEPATITIS B CAPSID ASSEMBLY MODULATORS HAVCR2, COPB1, HDLBP ALDH1A1 3850/4885CA12 3585/4885CA1 4284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.